CA Stock MarketDetailed Quotes
MBIO MindBio Therapeutics Corp
- 0.030
- 0.0000.00%
15min DelayMarket Closed Aug 8 14:32 ET
3.99MMarket Cap-1250P/E (TTM)
0.035High0.030Low17.00KVolume0.030Open0.030Pre Close540.00Turnover0.08552wk High0.01%Turnover Ratio133.05MShares0.01552wk Low-0.024EPS TTM3.99MFloat Cap0.560Historical HighLossP/E (Static)133.05MShs Float0.015Historical Low-0.034EPS LYR16.67%Amplitude--Dividend TTM-0.79P/B1Lot Size--Div YieldTTM
MindBio Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 433.23K | 197.42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --433.23K | --197.42K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 14.77%258.78K | 86.58%181.02K | -10.90%163.05K | -43.30%3.16M | 62.96%2.67M | -93.67%225.48K | -91.60%97.02K | 183K | 5.58M | 1.64M |
| Selling and administrative expenses | 4.19%210.25K | 69.76%123.61K | -12.05%105.14K | 10.94%3.22M | 17.79%2.79M | -17.42%201.81K | -93.44%72.82K | --119.55K | --2.9M | --2.37M |
| -Selling and marketing expense | -84.78%18.87K | -23.38%16.73K | -54.67%18.39K | 153.35%292.73K | 44.61%106.36K | 2,858.69%123.97K | -26.04%21.83K | --40.57K | --115.55K | --73.55K |
| -General and administrative expense | 145.88%191.38K | 109.64%106.88K | 9.84%86.75K | 5.03%2.93M | 16.94%2.69M | -67.59%77.84K | -95.28%50.99K | --78.98K | --2.79M | --2.3M |
| Research and development costs | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- | --2.46M | --498.87K |
| Depreciation amortization depletion | 70.01%40.25K | 100.00%48.4K | ---- | --0 | -401.09%-72.08K | 52.55%23.67K | --24.2K | --24.2K | --39.46K | --23.94K |
| -Depreciation and amortization | 70.01%40.25K | 100.00%48.4K | ---- | --0 | -401.09%-72.08K | 52.55%23.67K | --24.2K | --24.2K | --39.46K | --23.94K |
| Other operating expenses | --8.28K | --9K | 47.53%57.91K | -130.07%-54.74K | ---- | ---- | ---- | --39.25K | --182.08K | ---1.26M |
| Operating profit | 177.37%174.45K | 116.91%16.41K | 10.90%-163.05K | 43.30%-3.16M | -62.96%-2.67M | 93.67%-225.48K | 91.60%-97.02K | -183K | -5.58M | -1.64M |
| Net non-operating interest income (expenses) | 17.96%-56.47K | -14.51%-79.26K | 19.67%-56.21K | -149.64%-451.3K | -107.51%-243.27K | 96.72%-68.84K | 64.30%-69.22K | -69.97K | -180.78K | 3.24M |
| Non-operating interest expense | -17.96%56.47K | 14.51%79.26K | -19.67%56.21K | 149.64%451.3K | 107.51%243.27K | -96.72%68.84K | -64.30%69.22K | --69.97K | --180.78K | ---3.24M |
| Other net income (expenses) | -548.24%-41.16K | 110.86%22.74K | -27.00%31.17K | 60.97%-668.23K | 69.09%-489.2K | 95.09%-6.35K | -209.27K | 42.7K | -1.71M | -1.58M |
| Gain on sale of security | -548.24%-41.16K | 116.30%34.1K | -27.00%31.17K | -190.03%-317.76K | -2,235.70%-420.93K | 95.09%-6.35K | ---209.27K | --42.7K | ---109.56K | --19.71K |
| Special income (charges) | ---- | ---11.37K | ---- | 101.52%24.28K | ---- | ---- | --0 | ---- | ---1.6M | ---- |
| -Less:Other special charges | ---- | --11.37K | ---- | -101.52%-24.28K | ---- | ---- | ---- | ---- | --1.6M | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---374.75K | ---92.55K | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 125.55%76.82K | 89.32%-40.12K | 10.55%-188.09K | 42.65%-4.29M | -15,934.41%-3.4M | 94.81%-300.67K | 72.16%-375.5K | -210.27K | -7.47M | 21.47K |
| Income tax | 0 | 0 | 0 | 0 | ||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 125.55%76.82K | 89.32%-40.12K | 10.55%-188.09K | 42.65%-4.29M | -15,934.41%-3.4M | 94.81%-300.67K | 72.16%-375.5K | -210.27K | -7.47M | 21.47K |
| Net income continuous operations | 125.55%76.82K | 89.32%-40.12K | 10.55%-188.09K | 42.65%-4.29M | -15,934.41%-3.4M | 94.81%-300.67K | 72.16%-375.5K | ---210.27K | ---7.47M | --21.47K |
| Noncontrolling interests | -312 | |||||||||
| Net income attributable to the company | 125.55%76.82K | 89.32%-40.12K | 10.70%-187.77K | 42.65%-4.29M | -15,934.41%-3.4M | 94.81%-300.67K | 72.16%-375.5K | -210.27K | -7.47M | 21.47K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 125.55%76.82K | 89.32%-40.12K | 10.70%-187.77K | 42.65%-4.29M | -15,934.41%-3.4M | 94.81%-300.67K | 72.16%-375.5K | -210.27K | -7.47M | 21.47K |
| Diluted earnings per share | 125.53%0.0006 | 89.30%-0.0003 | -7.91%-0.0017 | 30.72%-0.0389 | -15,973.91%-0.0256 | 94.81%-0.0023 | 72.16%-0.0028 | -0.0016 | -0.0562 | 0.0002 |
| Basic earnings per share | 125.53%0.0006 | 89.30%-0.0003 | -7.91%-0.0017 | 30.72%-0.0389 | -15,973.91%-0.0256 | 94.81%-0.0023 | 72.16%-0.0028 | -0.0016 | -0.0562 | 0.0002 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg